跳至主要内容
临床试验/NCT03723577
NCT03723577撤回不适用

A Case Series Evaluating a Fibrillar Collagen Powder Dressing to Treat Chronic, Stalled Lower-extremity Wounds

Medline Industries1 个研究点 分布在 1 个国家开始时间: 2018年11月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Change in wound size over twelve week period

研究概览

简要总结

Patients who meet the inclusion criteria will be provided with fibrillar collagen powder dressing. The powder dressing will be used in accordance with its label. After cleansing the wound by the clinical site staff, the powder is placed directly on the wound, and then the wound will be covered with an appropriate moisture retentive secondary dressing. Patients will visit the clinic twice a week to have the powder re-applied. Wound evaluations will take place once a week at the outpatient clinic, with the intervention lasting up to twelve weeks. Concurrent standard of care, such as compression for venous ulcers, will be provided.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Has one of the following types of wounds below the knee: diabetic ulcers, pressure ulcers, venous ulcers, ulcers of mixed-vascular origin, traumatic wounds, or post-surgical wounds
  • •Wound has been present for at least four weeks
  • •Wound is free of necrotic tissue or debridement practices will take place prior to initial visit in order to remove necrotic tissue
  • •Wound has failed at least one wound care treatment
  • •Wound size is between 1 and 100 square centimeters
  • •Patient has adequate circulation as demonstrated by biphasic or triphasic Doppler waveform, measured within three months prior to study enrollment. If monophasic on exam, then non-invasive tests must display Ankle Brachial Index greater than 0.8 and no worse than mild disease on segmental pressures.
  • •Wound is confirmed as being free of infection and absence of osteomyelitis

排除标准

  • •Pregnant, planning to become pregnant during the study timeframe, or breast feeding
  • •Unable or unwilling to receive porcine collagen
  • •Wound is infected or presence of osteomyelitis
  • •Allergy or sensitivity to collagen
  • •Inability, in the opinion of the Investigator to follow protocol requirements, attend follow up visits in a timely manner, or otherwise comply with the requirements of the protocol

研究组 & 干预措施

Fibrillar Collagen Powder Dressing

Experimental

干预措施: Fibrillar collagen powder dressing (Device)

结局指标

主要结局

Change in wound size over twelve week period

时间窗: Baseline to 84 days

次要结局

  • Change in Bates-Jensen Wound Assessment Tool(Baseline to 84 days)
  • Change in reported pain level(Baseline to 84 days)

研究者

发起方
Medline Industries
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验